Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease

A new study suggests that GLP-1 receptor agonists (like Ozempic and Wegovy) are associated with better outcomes in people with type 2 diabetes and peripheral artery disease (PAD) compared to metformin. Patients taking GLP-1 medications required fewer procedures to restore blood f